English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/90309
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Evolution of serum biochemical indicators in anorexia nervosa patients: a 1-year follow-up study

AutorNova, Esther ; López-Vidriero, Irene; Varela, P.; Casas, J.; Marcos, Ascensión
Palabras claveRefeeding
Red blood cells
Restricting-type anorexia nervosa
Serum biochemical markers
Serum enzymatic activities.
Fecha de publicación2008
EditorBlackwell Publishing
CitaciónJournal of Human Nutrition and Dietetics 21: 23- 30 (2008)
ResumenAbstract BACKGROUND: Long-term studies on the evolution of serum biochemical indicators in anorexia nervosa (AN) patients during treatment are lacking in the literature. Thus, a 1-year follow-up of serum biochemical parameters in a homogeneous group of AN patients was performed. METHODS: Fourteen restricting-type AN patients were studied on admission to hospital, after 1 month of inpatient treatment and after 6 and 12 months after admission. RESULTS: Red blood cell count (RBC) and haemoglobin, serum glucose, total protein and the enzyme activities aspartate aminotransferase (AST), alkaline phosphatase (AlP), lactate dehydrogenase (LDH) and creatine kinase (CK) were significantly lower in patients on admission than in the control group. Total protein, high-density lipoprotein cholesterol (HDL-c), AST, AlP and CK showed significant changes among time points (anova, P < 0.05). Significant correlations were found between the change in RBC, haemoglobin, haematocrit, and the change in weight and body mass index (r = 0.74-0.86; P < 0.01). High cholesterol and amylase activity were found at all time points. While AST, LDH and CK reached control values within 6 months of treatment, AlP was always lower. CONCLUSION: Serum AlP, hypercholesterolaemia and RBC seem to need longer periods of treatment with further weight gain to fully normalize. Therefore, these parameters should be monitored in AN patients long-term follow-up.
Identificadoresdoi: 10.1111/j.1365-277X.2007.00833.x.
issn: 1365-277X
Aparece en las colecciones: (IF) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
450392.pdf81,99 kBUnknownVisualizar/Abrir
Mostrar el registro completo

Artículos relacionados:

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.